Device enhancement or recall? US FDA sets out decision path
This article was originally published in Clinica
Executive Summary
The US FDA has sought to further clarify guidelines it issued on 15 October on whether manufacturers who make changes to a medical device that is already on the market in US are enhancing it or actually effecting a recall.